Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/22/2012 | US20120294928 Method of treating scars and b-catenin-mediated disorders using nefopam compounds |
11/22/2012 | US20120294926 Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs |
11/22/2012 | US20120294924 Peptide-Lipid Conjugates And Uses Thereof |
11/22/2012 | US20120294915 Oral care compositions and methods |
11/22/2012 | US20120294913 Method for manufacturing aloe powder |
11/22/2012 | US20120294910 Method for treating a wound |
11/22/2012 | US20120294909 Method for inhibiting adhesion formation |
11/22/2012 | US20120294908 Placental tissue grafts and improved methods of preparing and using the same |
11/22/2012 | US20120294907 Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs |
11/22/2012 | US20120294906 Sericin extracted fabrics |
11/22/2012 | US20120294905 Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR) |
11/22/2012 | US20120294904 Polysialic acid-based n-trimethyl chitosan gel nanoparticles for systemic drug delivery |
11/22/2012 | US20120294903 Methods and systems of making nanostructures |
11/22/2012 | US20120294902 Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope |
11/22/2012 | US20120294901 Novel cochleate formulations |
11/22/2012 | US20120294900 Phosphorylated and Branched Dihydroxy-Pentane-Dione (DPD) Analogs as Quorum Sensing Inhibitors in Bacteria |
11/22/2012 | US20120294899 Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV |
11/22/2012 | US20120294898 Injectable dbm for soft tissue repair |
11/22/2012 | US20120294890 Recombinant Parainfluenza Virus Expression Systems And Vaccines |
11/22/2012 | US20120294809 Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof |
11/22/2012 | US20120294806 Drug carrier with thermal sensitivity, manufacturing method thereof, and use thereof |
11/22/2012 | US20120292797 Solid pharmaceutical dispersions with enhanced bioavailability |
11/22/2012 | CA2836643A1 Dry powder vancomycin compositions and associated methods |
11/22/2012 | CA2836405A1 Controlled release nasal testosterone gels, methods and pre-filled multi-dose applicator systems for pernasal administration |
11/22/2012 | CA2836398A1 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism |
11/22/2012 | CA2836317A1 Charge triggering of self-organized nanoparticles |
11/22/2012 | CA2836273A1 Thermostable vaccine compositions and methods of preparing same |
11/22/2012 | CA2836070A1 Container closure system with integral antimicrobial additives |
11/22/2012 | CA2835967A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response |
11/22/2012 | CA2835940A1 Intranasal pharmaceutical dosage forms comprising naloxone |
11/22/2012 | CA2835927A1 Compositions, methods & systems for respiratory delivery of two or more active agents |
11/22/2012 | CA2835911A1 Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
11/22/2012 | CA2835845A1 Drug delivery system |
11/22/2012 | CA2835810A1 Pharmaceutical compositions |
11/22/2012 | CA2834813A1 Skin and hair regeneration using polysaccharide-based hydrogels |
11/22/2012 | CA2834710A1 Compositions and methods for the treatment of skin diseases |
11/22/2012 | CA2826725A1 High concentration olopatadine ophthalmic composition |
11/21/2012 | EP2524701A2 Pharmaceutical composition and method for producing the same |
11/21/2012 | EP2524700A1 Mucinous glycoprotein (muc-1) vaccine |
11/21/2012 | EP2524698A1 Insulin preparation |
11/21/2012 | EP2524692A1 Anti-inflammatory analgesic adhesive patch for external use |
11/21/2012 | EP2524690A1 Method for making customised nanoparticles, nanoparticles and use thereof |
11/21/2012 | EP2524689A1 Oral preparation having improved quality |
11/21/2012 | EP2524688A1 Composition for modified release comprising ranolazine |
11/21/2012 | EP2524687A2 Edible jelly-form composition, jelly-form preparation and method for producing jelly-form preparation |
11/21/2012 | EP2524686A1 Pigmentation-preventing or -ameliorating agent |
11/21/2012 | EP2523959A1 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
11/21/2012 | EP2523944A1 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating |
11/21/2012 | EP2523712A1 Preservative free insulin formulations and systems and methods for aerosolizing |
11/21/2012 | EP2523691A1 Halogenated ether complex |
11/21/2012 | EP2523690A2 Compositions comprising pigment particles entrapped in collapsed polymeric microspheres, and methods of making the same |
11/21/2012 | EP2523670A1 Method for producing reservoir layer for hoof treatment and reservoir layer |
11/21/2012 | EP2523667A2 Lyophilized cake formulations |
11/21/2012 | EP2523660A2 Solid-forming local anesthetic formulations for pain control |
11/21/2012 | EP2523659A1 Skin mounted medical patch device |
11/21/2012 | EP2523658A1 A matrix composition for delivery of hydrophobic actives |
11/21/2012 | EP2523657A1 Pharmaceutical composition and dosage forms of elinogrel and methods of use thereof |
11/21/2012 | EP2523656A1 Crosslinked hydrogels and methods of making and using thereof |
11/21/2012 | EP2523655A2 Pharmaceutical compositions for oral administration of insulin peptides |
11/21/2012 | EP2523654A2 Immediate release compositions of acid labile drugs |
11/21/2012 | EP2523653A2 Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs |
11/21/2012 | EP2260833B1 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic |
11/21/2012 | CN202537982U Compound loratadine ibuprofen pseudoephedrine sulfate controlled release tablet |
11/21/2012 | CN202537981U Nitroglycerin patch |
11/21/2012 | CN202537980U External application paste patch |
11/21/2012 | CN202537979U Cataplasm |
11/21/2012 | CN202537978U Buccal and swallow capsule |
11/21/2012 | CN202537977U Taxol injection |
11/21/2012 | CN202537976U Hydroxycamptothecin injection |
11/21/2012 | CN1976581B Use of ether group-containing polymers as solubilizers |
11/21/2012 | CN1950110B Cyclodextrin inclusion complexes of pyrimidine-2,4,6-triones |
11/21/2012 | CN102791368A Fine-particle dispersion liquid manufacturing method and fine-particle dispersion liquid manufacturing apparatus |
11/21/2012 | CN102791294A Particles for multiple agent delivery |
11/21/2012 | CN102791272A Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
11/21/2012 | CN102791271A Method for improving dissolvability of anticoagulant |
11/21/2012 | CN102791270A Methods and compositions for applying moxifloxacin to the ear |
11/21/2012 | CN102791267A Anti-inflammatory analgesic adhesive patch for external use |
11/21/2012 | CN102791259A Nanostructure-enhanced platelet binding and hemostatic materials and structures |
11/21/2012 | CN102791258A Extended release formulations of rasagiline and uses thereof |
11/21/2012 | CN102791257A Granules for pharmaceutical preparations, methods and apparatus for their production |
11/21/2012 | CN102791256A Nanoparticulate candesartan cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them |
11/21/2012 | CN102791255A Micelle compositions and process for the preparation thereof |
11/21/2012 | CN102791254A Cell tissue gel containing collagen and hyaluronan |
11/21/2012 | CN102791151A Process for preparing products comprising stabilised actives and compositions comprising same |
11/21/2012 | CN102787382A Method for preparing natural material inorganic nanoparticle composite nano-fiber through electrostatic spinning |
11/21/2012 | CN102786675A Block copolymer and synthesis method thereof, and preparation method of nano particles |
11/21/2012 | CN102784600A Preparation method of lutein microcapsule |
11/21/2012 | CN102784389A Preparation method of Mycobacterium tuberculosis Ag85A oral DNA vaccine |
11/21/2012 | CN102784386A Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
11/21/2012 | CN102784382A Argatroban drug composition and preparation method and application of argatroban drug composition |
11/21/2012 | CN102784323A Kudzuvine root-radix angelicae-oolong granule and manufacture method thereof |
11/21/2012 | CN102784299A External use ointment for promoting wound healing without scar pigment and preparation method of external use ointment |
11/21/2012 | CN102784294A Navel plaster for treating infertility, and its preparation method |
11/21/2012 | CN102784293A Tablet for preventing and treating nephrotic syndrome |
11/21/2012 | CN102784284A Preparation method of sugar-free oral liquid with anti-cancer effect |
11/21/2012 | CN102784283A Jujube seed nerve soothing tablet |
11/21/2012 | CN102784281A Chrysanthemum rhizoma anemarrhenae oral liquid |
11/21/2012 | CN102784275A Tongzhisurunjiang tablet for activating retardation and softening and preparation and quality control method thereof |
11/21/2012 | CN102784272A Traditional Chinese medicine application agent for preventing and treating tonsils and throat inflammation induced by respiratory tract infection, and preparation method thereof |
11/21/2012 | CN102784270A Oldenlandia diffusa detoxifcation oral liquid |